Erik Swain is the Executive Editor for Cardiology Today and Healio Cardiology. With a focus on cardiology and cardiovascular health, Erik covers a wide range of topics including clinical trials, treatment advancements, and medical research. His articles provide valuable insights and updates for healthcare professionals in the cardiology field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Erik's coverage primarily focuses on scientific and healthcare topics, specifically cardiovascular health, heart conditions, medical research, medications, and treatment options. His articles heavily rely on cited data to support the content.
Given Erik’s focus on scientific and healthcare topics with a reliance on data citations, he would likely be receptive to pitches from experts who can provide in-depth analysis of new medical research findings or breakthroughs in the field of cardiovascular health. Pitches should highlight access to credible data or studies that support their insights.
Since his geographic focus is not specified but the topics covered are universal issues related to healthcare and medicine, sources with expertise in these areas could reach out regardless of location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Erin T. Welsh Ma
SAN ANTONIO — Higher concentrations of some phthalate and plasticizer metabolites were associated with higher odds of metabolic syndrome in U.S. adolescents and young adults, according to an analysis presented at ObesityWeek.“Adolescence represents a pivotal stage in human development marked by rapid physical changes and exposure to toxic chemicals or the onset of metabolic disorders
By: Erin T. Welsh, Erik Swain
SAN ANTONIO — When asked common questions regarding anti-obesity medications, GPT-4 responses were easy to interpret, accurate and comparable to responses provided by the FDA, according to findings presented at ObesityWeek.
By: Erik Swain, Richard Smith
WASHINGTON — A bioadaptor implant adaptable to vessel physiology was linked to fewer target lesion failure events after 6 months compared with a drug-eluting stent, including in high-risk lesions, researchers reported.
By: Erik Swain, Erin T. Welsh
Video Player is loading. Play Video Play Mute Current Time Duration
By: Scott Buzby, Erik Swain
SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1
By: Erin T. Welsh, Erik Swain
SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.
By: Erik Swain
WASHINGTON — In an exploratory analysis of the PROTECTED TAVR trial of patients undergoing transcatheter aortic valve replacement, cerebral embolic
By: Erik Swain, Erin T. Welsh
SAN ANTONIO — Redevelopment of low-income minority communities may help to reduce obesity disparities in this patient population, according to findings presented at ObesityWeek.
By: Cassandra Jenkins, Erik Swain
Older Chinese adults with hearing, visual or dual sensory impairment had higher risk for CVD compared with those without sensory impairment, according to a study published in the Journal of the American Heart Association
By: Susan Weiner, Bonnie R. Giller, Rdn Cdn Cdces, Erik Swain
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Bonnie R. Giller, MS, RDN, CDN, CD CES registered dietitian nutritionist and certified intuitive
(833) 317-6278 
